Should NICE evaluate complementary and alternative medicines?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 17347234.
- Also identified by PMC identifier 1819538.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Demand for complementary and alternative medicine is high despite limited evidence.<b> Linda Franck and colleagues</b> believe that a thorough review by NICE would benefit the NHS and patients, but <b>David Colquhoun</b> argues that it cannot afford to re-examine evidence that has shown little benefit
Medical subject headings
- Complementary Therapies